| scholarly article | Q13442814 |
| P2093 | author name string | Toshiyuki Yamamoto | |
| P2860 | cites work | Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1 | Q24562120 |
| Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy | Q24804272 | ||
| Between adaptive and innate immunity: TLR4-mediated perforin production by CD28null T-helper cells in ankylosing spondylitis | Q24813041 | ||
| Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis | Q24816628 | ||
| Psoriatic arthritis joint fluids are characterized by CD8 and CD4 T cell clonal expansions appear antigen driven | Q28143006 | ||
| Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis | Q29620506 | ||
| Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis | Q30525640 | ||
| Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion | Q34320131 | ||
| Halting angiogenesis by non-viral somatic gene therapy alleviates psoriasis and murine psoriasiform skin lesions | Q34428875 | ||
| An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. | Q34534186 | ||
| Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis | Q77993356 | ||
| Interleukin-17 promotes angiogenesis and tumor growth | Q78460523 | ||
| Toll-like receptor-2 expression is upregulated in antigen-presenting cells from patients with psoriatic arthritis: a pathogenic role for innate immunity? | Q79446064 | ||
| Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis | Q80418748 | ||
| Differential Toll-like receptor-dependent collagenase expression in chondrocytes | Q80656444 | ||
| Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus | Q81349191 | ||
| Defining upstream elements of psoriasis pathogenesis: an emerging role for interferon alpha | Q81503062 | ||
| Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation | Q81621807 | ||
| Topical application of anti-angiogenic peptides based on pigment epithelium-derived factor can improve psoriasis | Q82446840 | ||
| IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis | Q83163682 | ||
| Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis | Q85036491 | ||
| IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. | Q51745791 | ||
| Expression of MDC/CCL22 and its receptor CCR4 in rheumatoid arthritis, psoriatic arthritis and osteoarthritis. | Q51888786 | ||
| Angiopoietins, growth factors, and vascular morphology in early arthritis. | Q52860641 | ||
| Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis | Q59042887 | ||
| Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α | Q59074915 | ||
| Effective Therapy with Anti-TNF- in Patients with Psoriatic Arthritis Is Associated with Decreased Levels of Metalloproteinases and Angiogenic Cytokines in the Sera and Skin Lesions | Q59154938 | ||
| Cytokine profiles during infliximab monotherapy in psoriatic arthritis | Q59154943 | ||
| Prominent Production of IL-20 by CD68+/CD11c+ Myeloid-Derived Cells in Psoriasis: Gene Regulation and Cellular Effects | Q60683098 | ||
| Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis | Q72085457 | ||
| Localized monocyte chemotactic protein-1 production correlates with T cell infiltration of synovium in patients with psoriatic arthritis | Q73090176 | ||
| Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid | Q73128367 | ||
| Mast cells in the synovium of patients with psoriasis arthropathy | Q73616680 | ||
| Upregulation of cytokine receptors sTNF-R55, sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid | Q74151287 | ||
| The T cell receptor repertoire in psoriatic synovitis is restricted and T lymphocytes expressing the same TCR are present in joint and skin lesions | Q74793572 | ||
| Predominance of CD8+ T lymphocytes in psoriatic arthritis | Q77762643 | ||
| Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis | Q34555643 | ||
| IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis | Q34577866 | ||
| Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis | Q34896320 | ||
| The IL-23/Th17 axis in the immunopathogenesis of psoriasis | Q34969188 | ||
| A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice | Q35083718 | ||
| T cell derived cytokines in psoriatic arthritis synovial fluids | Q35547611 | ||
| Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment | Q35638455 | ||
| Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium | Q35749232 | ||
| Inferences, questions and possibilities in Toll-like receptor signalling | Q35829752 | ||
| Ectopic lymphoid neogenesis in psoriatic arthritis | Q35953359 | ||
| Immunopathology of psoriasis and psoriatic arthritis | Q36040037 | ||
| Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses | Q36294340 | ||
| Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. | Q36402885 | ||
| Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2 | Q36876705 | ||
| The pathobiology of psoriatic synovium | Q37182472 | ||
| CCR6 is required for IL-23-induced psoriasis-like inflammation in mice | Q37286597 | ||
| Angiogenesis drives psoriasis pathogenesis | Q37534974 | ||
| The role of angiogenesis in the pathogenesis of psoriasis | Q37622941 | ||
| Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis--a possible target for novel therapies? | Q37739648 | ||
| Synovitis in psoriatic arthritis: immunohistochemistry, comparisons with rheumatoid arthritis, and effects of therapy | Q37866683 | ||
| Psoriatic arthritis: from a dermatological perspective | Q37895780 | ||
| New insight into the functions of the interleukin-17 receptor adaptor protein Act1 in psoriatic arthritis. | Q38056967 | ||
| Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis | Q39539886 | ||
| Immunopathogenesis of psoriasis | Q40175802 | ||
| Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis | Q40974392 | ||
| Functional role of IL-22 in psoriatic arthritis | Q42326323 | ||
| IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14/p40 transgenic mice: evidence for enhanced cutaneous immunity | Q42441623 | ||
| Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice | Q42458183 | ||
| Upregulation of hypoxia-inducible factors in normal and psoriatic skin | Q42512503 | ||
| The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis | Q42853439 | ||
| Interleukin 13 in synovial fluid and serum of patients with psoriatic arthritis | Q43051359 | ||
| TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis | Q44452432 | ||
| Vascular endothelial growth factor VEGF189 induces human neutrophil chemotaxis in extravascular tissue via an autocrine amplification mechanism | Q44767194 | ||
| Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pannus junction | Q44960764 | ||
| Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis | Q45859481 | ||
| Clinical analysis of 21 patients with psoriasis arthropathy | Q46500742 | ||
| Synovial VLA-1+ T cells display an oligoclonal and partly distinct repertoire in rheumatoid and psoriatic arthritis | Q46611935 | ||
| Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation | Q46931416 | ||
| Toll-like receptors and rheumatoid arthritis | Q47982795 | ||
| Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy | Q49110903 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 630620 | |
| P577 | publication date | 2013-05-30 | |
| P1433 | published in | ISRN Dermatology | Q26842610 |
| P1476 | title | Angiogenic and inflammatory properties of psoriatic arthritis | |
| P478 | volume | 2013 |
| Q41208827 | Angiogenesis Dysregulation in Psoriatic Arthritis: Molecular Mechanisms |
| Q49586531 | Anti-angiogenic effects of biotechnological therapies in rheumatic diseases |
| Q41975429 | Clinical and Contrast-Enhanced Ultrasound Echography Outcomes in Psoriatic Arthritis Patients after One Year of Continuous Therapy with Anti-TNF Drugs |
| Q35667354 | Gene Expression Profiling in Peripheral Blood Cells and Synovial Membranes of Patients with Psoriatic Arthritis |
| Q42128121 | Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry |
| Q34538249 | Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled perio |
| Q43098080 | Metabolomics in psoriatic disease: pilot study reveals metabolite differences in psoriasis and psoriatic arthritis |
| Q28072557 | Optimal management of dactylitis in patients with psoriatic arthritis |
| Q92127466 | Psoriatic Arthritis: What is Happening at the Joint? |
| Q38160325 | Putative effects of potentially anti-angiogenic drugs in rheumatic diseases |
| Q46155530 | Serum YKL-40 in psoriasis with and without arthritis; correlation with disease activity and high-resolution power Doppler ultrasonographic joint findings. |
| Q35308947 | The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications |
Search more.